Clinical Significance of Superficial Vein Thrombosis
Overview
Authors
Affiliations
Objective: To evaluate the clinical implications of superficial thrombophlebitis (STP) including its demographic characteristics, distribution, risk factors, relationship with deep vein thrombosis (DVT), pulmonary embolism (PE), diagnosis and management.
Methods: Data were collected from relevant papers using a MEDLINE search and an extensive bibliography review. Studies were considered only when they contained pertinent material to STP. Thirty-seven papers were analysed.
Results: The diversity of patients and methods used in the different studies made the comparison among them difficult. STP is a common condition with an underestimated prevalence. There are many risk factors associated with STP but the strongest relation was seen with hypercoagulable states. Malignancy may be another important factor but the strength of this association remains unknown. Coexistence with DVT was found in 6-53%. PE occurred in 0-33.3%. Propagation to DVT ranged from 2.6 to 15%. Treatment has not been standardised and may include elastic compression, anti-inflammatory drugs, anticoagulation and surgery.
Conclusion: The limited number of prospective randomised studies on STP does not allow strong recommendations to be given. Although STP most often is perceived as benign, it can coexist with or progress to DVT, and even give rise to PE. It is also associated with hypercoagulability and malignancy.
Current Diagnostic and Therapeutic Challenges in Superficial Venous Thrombosis.
Balahura A, Florescu A, Barboi T, Weiss E, Miricescu D, Jurcut C Medicina (Kaunas). 2024; 60(9).
PMID: 39336507 PMC: 11434259. DOI: 10.3390/medicina60091466.
Facial vein thrombophlebitis post facial skin infection: a case report and review of the literature.
Alshalawi M, Almoamary A, Alrajhi S, Alkanhal R, Alsogair R, Albarrak D SAGE Open Med Case Rep. 2024; 12:2050313X241283265.
PMID: 39314216 PMC: 11418322. DOI: 10.1177/2050313X241283265.
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.
Nguyen A, Curtis K, Tepper N, Kortsmit K, Brittain A, Snyder E MMWR Recomm Rep. 2024; 73(4):1-126.
PMID: 39106314 PMC: 11315372. DOI: 10.15585/mmwr.rr7304a1.
Zhang Y, Zhou W, Zhou J, Chu W, Fan J, Lu H BMC Musculoskelet Disord. 2024; 25(1):429.
PMID: 38824539 PMC: 11144313. DOI: 10.1186/s12891-024-07545-4.
van Royen F, van Smeden M, van Doorn S, Rutten F, Geersing G BMJ Open. 2024; 14(4):e074818.
PMID: 38626964 PMC: 11029256. DOI: 10.1136/bmjopen-2023-074818.